Search Results - "Bertz, Simone"

TERT promoter mutation analysis as a surrogate to morphology and immunohistochemistry in problematic spindle cell lesions of the urinary bladder.

Authors: Bertz, Simone Stöhr, Robert Gaisa, Nadine T et al.

Source: Histopathology. Dec2020, Vol. 77 Issue 6, p949-962. 14p.

Substaging by estimating the size of invasive tumour can improve risk stratification in pT1 urothelial bladder cancer-evaluation of a large hospital-based single-centre series.

Authors: Bertz, Simone Denzinger, Stefan Otto, Wolfgang et al.

Source: Histopathology. Oct2011, Vol. 59 Issue 4, p722-732. 11p. 1 Color Photograph, 3 Charts, 4 Graphs.

GPS1 Exon 9 Mutations Represent a Rare Genetic Event in Penile Squamous Cell Carcinoma Pathogenesis.

Authors: Tögel, Lars Elsner, Felix Wendler, Olaf et al.

Source: International Journal of Molecular Sciences. Mar2026, Vol. 27 Issue 5, p2460. 14p.

Adhesion GPCR Gpr126 (Adgrg6) Expression Profiling in Zebrafish, Mouse, and Human Kidney.

Authors: Cazorla-Vázquez, Salvador Kösters, Peter Bertz, Simone et al.

Source: Cells (2073-4409). Aug2023, Vol. 12 Issue 15, p1988. 19p.

Urothelial Bladder Cancer: An Update on Molecular Pathology with Clinical Implications.

Authors: Bertz, Simone Eckstein, Markus Stoehr, Robert et al.

Source: European Urology Supplements. Dec2017, Vol. 16 Issue 12, p272-294. 23p.

Combination of CK20 and Ki-67 Immunostaining Analysis Predicts Recurrence, Progression, and Cancer-Specific Survival in pT1 Urothelial Bladder Cancer.

Authors: Bertz, Simone Otto, Wolfgang Denzinger, Stefan et al.

Source: European Urology. Jan2014, Vol. 65 Issue 1, p218-226. 9p.

Transurethral en bloc submucosal hydrodissection vs conventional resection for resection of non‐muscle‐invasive bladder cancer (HYBRIDBLUE): a randomised, multicentre trial.

Authors: Gakis, Georgios Karl, Alexander Bertz, Simone et al.

Source: BJU International. Oct2020, Vol. 126 Issue 4, p509-519. 11p.

Elevated Microsatellite Alterations at Selected Tetranucleotide Repeats (EMAST) in Penile Squamous Cell Carcinoma—No Evidence for a Role in Carcinogenesis.

Authors: Fiegl, August Wendler, Olaf Giedl, Johannes et al.

Source: Current Oncology. Oct2024, Vol. 31 Issue 10, p5752-5761. 10p.

Mutational frequencies of CD79B and MYD88 vary greatly between primary testicular DLBCL and gastrointestinal DLBCL.

Authors: Frick, Mareike Bettstetter, Marcus Bertz, Simone et al.

Source: Leukemia & Lymphoma. May2018, Vol. 59 Issue 5, p1260-1263. 4p.

Prognostic and Predictive Potential of CCL5 Expression in Muscle-Invasive Bladder Cancer Patients.

Authors: Smolka, Cedric Eckstein, Markus Jung, Rudolf et al.

Source: International Journal of Molecular Sciences. Jun2024, Vol. 25 Issue 12, p6325. 19p.

Gene Expression Profiling Provides an Improved Characterization of CD79B -Mutated Diffuse Large B-Cell Lymphomas.

Authors: Grossmann, Luis Jagla, Wolfgang Bettstetter, Marcus et al.

Source: Journal of Personalized Medicine. Nov2025, Vol. 15 Issue 11, p548. 13p.

Prognostic impact of molecular muscle-invasive bladder cancer subtyping approaches and correlations with variant histology in a population-based mono-institutional cystectomy cohort.

Authors: Weyerer, Veronika Stoehr, Robert Bertz, Simone et al.

Source: World Journal of Urology. Nov2021, Vol. 39 Issue 11, p4011-4019. 9p.

Prognostic impact of variant histologies in urothelial bladder cancer treated with radical cystectomy.

Authors: Claps, Francesco van de Kamp, Maaike W. Mayr, Roman et al.

Source: BJU International. Aug2023, Vol. 132 Issue 2, p170-180. 11p.

Distinct genetic alterations and luminal molecular subtype in nested variant of urothelial carcinoma.

Authors: Weyerer, Veronika Weisser, Rebecca Moskalev, Evgeny A et al.

Source: Histopathology. Dec2019, Vol. 75 Issue 6, p865-875. 11p. 2 Diagrams, 5 Charts.

No Evidence of Microsatellite Instability and Loss of Mismatch-Repair-Protein Expression in Squamous Cell Carcinoma of the Penis.

Authors: Stoehr, Robert Wendler, Olaf Giedl, Johannes et al.

Source: Pathobiology. 2019, Vol. 86 Issue 2/3, p145-151. 7p.

The World Health Organization 1973 classification system for grade is an important prognosticator in T1 non‐muscle‐invasive bladder cancer.

Authors: Putte, Elisabeth E. Fransen Bosschieter, Judith Kwast, Theo H. et al.

Source: BJU International. Dec2018, Vol. 122 Issue 6, p978-985. 8p.

CDKN2A as transcriptomic marker for muscle-invasive bladder cancer risk stratification and therapy decision-making.

Authors: Worst, Thomas S. Weis, Cleo-Aron Stöhr, Robert et al.

Source: Scientific Reports. 9/26/2018, Vol. 8 Issue 1, p1-11. 11p.

Is gender becoming relevant in uro-oncological research? A bibliographical analysis.

Authors: Kunath, Frank Keck, Bastian Bertz, Simone et al.

Source: World Journal of Urology. Oct2013, Vol. 31 Issue 5, p1065-1072. 8p.

Infiltrative lamina propria invasion pattern as an independent predictor for cancer‐specific and overall survival of instillation treatment‐naïve stage T1 high‐grade urothelial bladder cancer.

Authors: Otto, Wolfgang Van Rhijn, Bas W. G. Breyer, Johannes et al.

Source: International Journal of Urology. May2018, Vol. 25 Issue 5, p442-449. 8p.

Large nested variant of urothelial carcinoma: a clinicopathological study of 36 cases.

Authors: Compérat, Eva McKenney, Jesse K Hartmann, Arndt et al.

Source: Histopathology. Nov2017, Vol. 71 Issue 5, p703-710. 8p. 2 Color Photographs, 4 Charts.